Table 3.
Correlation of clinical factors with 25(OH)D3 among NAFLD and controls.
| Clinical factors | NAFLD | Control | Total | |||
|---|---|---|---|---|---|---|
| r | p | r | p | r | p | |
| 25(OH)D3 (ng/mL) | ||||||
| BMI (kg/m2) | -0.122 | 0.031 | 0.154 | 0.007 | -0.025 | 0.540 |
| WC (cm) | -0.088 | 0.124 | 0.131 | 0.023 | -0.019 | 0.637 |
| ALT (U/L) | -0.149 | 0.008 | 0.112 | 0.050 | -0.016 | 0.690 |
| AST (U/L) | 0.012 | 0.838 | 0.129 | 0.024 | 0.057 | 0.156 |
| ALP (U/L) | -0.060 | 0.288 | 0.015 | 0.791 | -0.030 | 0.456 |
| GGT (U/L) | -0.015 | 0.785 | -0.010 | 0.861 | -0.036 | 0.377 |
| INS (μIU/mL) | -0.024 | 0.882 | 0.232 | 0.236 | -0.027 | 0.823 |
| GLU (mmol/L) | 0.085 | 0.133 | 0.014 | 0.812 | -0.065 | 0.108 |
| HOMA-IR | -0.059 | 0.705 | 0.213 | 0.276 | -0.048 | 0.693 |
| TC (mmol/L) | 0.004 | 0.945 | -0.029 | 0.615 | -0.021 | 0.610 |
| TG (mmol/L) | -0.104 | 0.068 | -0.078 | 0.175 | -0.124 | 0.002 |
| HDL(mmol/L) | 0.090 | 0.112 | -0.079 | 0.166 | 0.058 | 0.153 |
| LDL (mmol/L) | -0.054 | 0.339 | 0.010 | 0.858 | -0.038 | 0.348 |
NAFLD non-alcoholic fatty liver disease; BMI, body mass index; WC, Waist circumference; SBP, Systolic blood pressure; DBP, Diastolic blood pressure; ALT, Alanine Transaminase; AST, Aspartate Aminotransferase; GGT, γ-glutamyl transpeptidase; ALP, alkaline phosphatase; ALB, Albumin; INS, Insulin; GLU, glucose; HOMA-IR, Homeostasis model assessment insulin resistance; TC, total cholesterol; TG, triglyceride; HDL, High-density lipoprotein; LDL, Low-density lipoprotein.